View in EDS

NRF2 activation in cancer and overview of NRF2 small molecule inhibitors.

Saved in:
Bibliographic Details
Title: NRF2 activation in cancer and overview of NRF2 small molecule inhibitors.
Authors: Ngo HH; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, 32 Dongguk-Ro, Goyang, 10326, Gyeonggi-Do, Korea., Yu BY; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, 32 Dongguk-Ro, Goyang, 10326, Gyeonggi-Do, Korea., Lee JE; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, 32 Dongguk-Ro, Goyang, 10326, Gyeonggi-Do, Korea., Kim H; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, 32 Dongguk-Ro, Goyang, 10326, Gyeonggi-Do, Korea. hwkim8906@dongguk.edu., Keum YS; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, 32 Dongguk-Ro, Goyang, 10326, Gyeonggi-Do, Korea. keum03@dongguk.edu.
Source: Archives of pharmacal research [Arch Pharm Res] 2025 Aug; Vol. 48 (7-8), pp. 676-705. Date of Electronic Publication: 2025 Aug 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pharmaceutical Society of Korea Country of Publication: Korea (South) NLM ID: 8000036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1976-3786 (Electronic) Linking ISSN: 02536269 NLM ISO Abbreviation: Arch Pharm Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1976-3786
DOI:10.1007/s12272-025-01557-x